Categories
The FDA is warning that Veozah (fezolinetant), a medicine used to treat hot flashes due to menopause, can cause rare but serious liver injury. If there are signs and symptoms suggesting liver injury, stopping the medicine could prevent worsening liver injury.
Categories
El Campus Virtual de la OPS y la Academia de la OMS unen esfuerzos para ampliar la capacitación en salud en la región de las Américas
PAHO Virtual Campus and WHO Academy join forces to improve health training in the Region of the Americas
Cristina Mitchell
17 Dec 2024
Categories
FDA Approves New Treatment for Congenital Adrenal Hyperplasia
FDA Approves New Treatment for Congenital Adrenal Hyperplasia
http://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-congenital-adrenal-hyperplasia
Categories
FDA Roundup: December 13, 2024
FDA Roundup: December 13, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-13-2024
Categories
Drowning deaths decline globally but the most vulnerable remain at risk
Drowning deaths decline globally but the most vulnerable remain at risk
Oscar Reyes
13 Dec 2024
Categories
Buy-herbal.com Issues Voluntary Nationwide Recall of Nhan Sam Tuyet Lien Truy Phong Hoan Capsules Due to Undeclared Furosemide, Dexamethasone and Chlorpheniramine
12th December 2024, Flushing, New York, Buy-herbal.com is voluntarily recalling all lots within expiry of Nhan Sam Tuyet Lien Truy Phong Hoan Capsules to the consumer level. FDA analysis has found these products to contain undeclared Furosemide, Dexamethasone and Chlorpheniramine. Furosemide was fou
Categories
PAHO highlights the need to prioritize primary health care to advance towards universal health in the Americas
PAHO highlights the need to prioritize primary health care to advance towards universal health in the Americas
Cristina Mitchell
12 Dec 2024
Categories
Ocaliva (obeticholic acid) by Intercept Pharmaceuticals: Drug Safety Communication – Serious Liver Injury Being Observed in Patients without Cirrhosis
Based on its review of postmarket clinical trial data, the U.S. Food and Drug Administration (FDA) identified cases of serious liver injury among patients being treated for primary biliary cholangitis (PBC) with Ocaliva (obeticholic acid) who did not have cirrhosis of the liver.
Categories
La OPS reúne a las autoridades regulatorias de las Américas para fortalecer el acceso a tecnologías de salud y la autosuficiencia sanitaria
PAHO convenes regulatory authorities from the Americas to strengthen access to health technologies and promote self-sufficiency in health
Cristina Mitchell
11 Dec 2024
Categories
Early Alert: Infusion Pump Issue from Fresenius Kabi USA
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program